Filing Details

Accession Number:
0001209191-12-024946
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-30 18:50:53
Reporting Period:
2012-04-26
Filing Date:
2012-04-30
Accepted Time:
2012-04-30 18:50:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389072 Heartware International Inc. HTWR Surgical & Medical Instruments & Apparatus (3841) 980498958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321437 Lauren Farrell C/O Heartware International, Inc.
205 Newbury Street, Suite 101
Framingham MA 01701
Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-26 750 $28.00 750 No 4 M Direct
Common Stock Acquisiton 2012-04-26 535 $20.69 1,285 No 4 M Direct
Common Stock Acquisiton 2012-04-26 1 $27.23 1,286 No 4 M Direct
Common Stock Disposition 2012-04-26 1,286 $78.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-04-26 750 $0.00 750 $28.00
Common Stock Stock Option (right to buy) Disposition 2012-04-26 535 $0.00 535 $20.69
Common Stock Stock Option (right to buy) Disposition 2012-04-26 1 $0.00 1 $27.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,573 2011-09-16 2019-09-16 No 4 M Direct
2,038 2011-08-13 2018-08-13 No 4 M Direct
2,037 2010-02-22 2017-11-16 No 4 M Direct
Footnotes
  1. The purchase price of US$20.69 has been converted from AU$19.95 at the spot rate on the date of the transaction.
  2. The purchase price of US$27.23 has been converted from AU$26.25 at the spot rate on the date of the transaction.
  3. These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  4. The exercise price of US$20.69 has been converted from AU$19.95 at the spot rate on the date of the transaction.
  5. The exercise price of US$27.23 has been converted from AU$26.25 at the spot rate on the date of the transaction.